Goc A, Niedzwiecki A, Rath M.
J Appl Microbiol. 2015 Oct 12. doi: 10.1111/jam.12970. [Epub ahead of print]
Biofilm formation by Borrelia burgdorferi sensu lato.
Timmaraju VA, Theophilus PA, Balasubramanian K, Shakih S, Luecke DF, Sapi E.
FEMS Microbiol Lett. 2015 Aug;362(15):fnv120. doi: 10.1093/femsle/fnv120. Epub 2015 Jul 24.
Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms.
Meriläinen L, Herranen A, Schwarzbach A, Gilbert L.
Microbiology. 2015 Mar;161(Pt 3):516-27. doi: 10.1099/mic.0.000027. Epub 2015 Jan 6.
Feng J, Wang T, Zhang S, Shi W, Zhang Y.
PLoS One. 2014 Nov 3;9(11):e111809. doi: 10.1371/journal.pone.0111809. eCollection 2014.
Review of evidence for immune evasion and persistent infection in Lyme disease.
Berndtson K.
Int J Gen Med. 2013 Apr 23;6:291-306. doi: 10.2147/IJGM.S44114. Print 2013.
Characterization of biofilm formation by Borrelia burgdorferi in vitro.
Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N, Poruri A, Burugu D, Theophilus PA, Pham TV, Datar A, Dhaliwal NK, MacDonald A, Rossi MJ, Sinha SK, Luecke DF.
PLoS One. 2012;7(10):e48277. doi: 10.1371/journal.pone.0048277. Epub 2012 Oct 24.
The amber theory of Lyme arthritis: initial description and clinical implications.
Wormser GP, Nadelman RB, Schwartz I.
Clin Rheumatol. 2012 Jun;31(6):989-94. doi: 10.1007/s10067-012-1964-x. Epub 2012 Mar 13.
Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB.
Infect Drug Resist. 2011;4:97-113. doi: 10.2147/IDR.S19201. Epub 2011 May 3.
Lyme disease: the next decade.
Stricker RB, Johnson L.
Infect Drug Resist. 2011;4:1-9. doi: 10.2147/IDR.S15653. Epub 2011 Jan 7.
Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism.
Parveen N, Cornell KA.
Mol Microbiol. 2011 Jan;79(1):7-20. doi: 10.1111/j.1365-2958.2010.07455.x. Epub 2010 Nov 18. Review.
Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M.
J Bacteriol. 2005 Mar;187(5):1792-8.